Correction regarding adalimumab labelling.
George
G
Spencer-Green
D000068879:Adalimumab; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D004348:Drug Labeling; D006801:Humans; D014376:Tuberculosis / Q000139:chemically induced
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068879:Adalimumab